PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.

1. (1) Schedules of Controlled Substances.

   1. (A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.

      1. 1. Opiates. Unless specifically excepted

or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. A. Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)- 4-piperidinyl)-N- phenylacetamide) 9815
2. B. Acetylmethadol 9601
3. C. Acetyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide) 9821
4. D. N-(1-phenethylpiperidin- 4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: acryl fentanyl, acryloylfentanyl) 9811
5. E. AH-7921(3,4-dichloro- N-[(1-dimethylamino) cyclohexylmethyl] benzamide) 9551
6. F. Allylprodine 9602
7. G. Alphacetylmethadol (except levoalphacetylmethadol also known as levo-alphaacetylmethadol levothadyl acetate or LAAM) 9603
8. H. Alphameprodine 9604
9. I. Alphamethadol 9605
10. J. Alpha-methylfentanyl (N-1-(alphamethyl-betaphenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl- 2-phenylethyl)-4 ((N- propanilido) piperidine) 9814

1. K. Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N- phenylpropanamide)
2. L. Benzethidine
3. M. Betacetylmethadol
4. N. Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2- phenethyl)-4-piperidinyl)- N-phenylpropanamide)
5. O. Beta-hydroxy-3- methylfentanyl (other name: N-(1-(2-hydroxy-2-phenethyl)- 3-methyl-4-piperidinyl)-N- phenylpropanamide)
6. P. N-[1-[2-hydroxy-2-(thiophen- 2-yl) ethyl]piperidin-4-yl]- N-phenylpropionamide (Other names: beta-hydroxythiofentanyl)
7. Q. Betameprodine
8. R. Betamethadol
9. S. beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl) propionamide (Other name: β-methyl fentanyl)
10. T. beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)- N,3-diphenylpropanamide (Other names: β′-phenyl fentanyl; 3-phenylpropanoyl fentanyl)
11. U. Betaprodine
12. V. Clonitazene
13. W. Crotonyl fentanyl ((E)-N-(1- phenethylpiperidin-4-yl)-N- phenylbut-2-enamide)
14. X. N-(1-phenethylpiperidin- 4-yl)-N- Phenylcyclopentanecarboxamide (Other name: cyclopentyl fentanyl)
15. Y. Cyclopropyl fentanyl (N-(1- phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide)
16. Z. Dextromoramide AA. Diampromide BB. Diethylthiambutene
17. CC. Difenoxin
18. DD. Dimenoxadol EE. Dimepheptanol FF. Dimethylthiambutene GG. Dioxaphetyl butyrate HH. Dipipanone
19. II. Ethylmethylthiambutene JJ. Etonitazene KK. Etoxeridine
20. LL. Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) (phenyl)carbamate) 19 CSR 30-1
21. MM. N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4- yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 4-fluoroisobutyryl fentanyl, parafluoroisobutyryl fentanyl) NN. 2′-Fluoro orthofluorofentanyl (N-(1-(2- fluorophenethyl) piperidin- 4-yl)-N-(2-fluorophenyl) propionamide (Other names: 2′-fluoro 2- fluorofentanyl) OO. N-(1-phenethylpiperidin- 4-yl)-N-phenylfuran-2- carboxamide (Other names: furanyl fentanyl) PP. Furethidine QQ. Hydroxypethidine RR. N-(1-phenethylpiperidin- 4-yl)-N-phenylisobutyramide (Other name: isobutyryl fentanyl) SS. Ketobemidone TT. Levomoramide UU. Levophenacylmorphan
22. VV. Methoxyacetyl fentanyl (2-methoxy-N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide WW. 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) piperidin-4-yl)-N- phenylacetamide)
23. XX. 3-Methylfentanyl (N-(3- methyl-1-(2-phenylethyl)-4- piperidyl)-N- phenylproanamide), its optical and geometric isomers, salts, and salts of isomers YY. 3-Methylthiofentanyl (N- (3-methyl-1-(2- thienyl)ethyl-4-piperidinyl)- N-phenylpropanamide) ZZ. Morpheridine AAA. MPPP (1-methyl-4- phenyl-4- propionoxypiperidine) BBB. MT–45 (1-cyclohexyl- 4-(1,2-diphenylethyl) piperazine)
24. CCC. Noracymethadol
25. DDD. Norlevorphanol EEE. Normethadone FFF. Norpipanone (9560) AND SENIOR SERVICES

GGG. N-(2-fluorophenyl)-2- methoxy-N-(1- phenethylpiperidin-4- yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other name: ocfentanil) 9838 HHH. ortho-Fluoroacryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) acrylamide) 9852 III. ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl) butyramide (Other Name: 2-fluorobutyryl fentanyl) 9846 JJJ. ortho-Fluorofentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl) 9816 KKK. ortho-Fluoroisobutyryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)isobutyramide) 9853 LLL. ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (Other name: 2-methyl acetylfentanyl) 9848 MMM. ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (Other name: 2-methyl methoxyacetyl fentanyl) 9820 NNN. N-(4-chlorophenyl)-N- (1-phenethylpiperidin- 4-yl)isobutyramide (Other name: parachloroisobutyryl fentanyl) 9826 OOO. para-Fluorobutyryl

1. 2. Opium derivatives. Unless specifical-

fentanyl (N-(4- ly excepted or unless listed in another schedfluorophenyl)-N-(1- ule, any of the following opium derivatives, phenethylpiperidin-4- its salts, isomers, and salts of isomers whenyl)butyramide) 9823 ever the existence of such salts, isomers, and PPP. Para-fluorofentanyl(N- salts of isomers is possible within the specif- (4-fluorophenyl)-N-(1-(2- ic chemical designation: phenethyl)-4-piperidinyl) propanamide 9812 QQQ. para-Fluoro furanyl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)furan-2-carboxamide) 9854 RRR. para-Methoxybutyryl fentanyl (N-(4- methoxyphenyl)-N-(1- phenethylpiperidin-4-yl) butyramide) SSS. para-Methylfentanyl (N-(4-methylphenyl)-N- (1-phenethylpiperidin-4-yl) propionamide (Other Name: 4- methylfentanyl) TTT. PEPAP (1-(-2-phenethyl)- 4-phenyl-4- acetoxypiperidine) UUU. Phenadoxone VVV. Phenampromide WWW. Phenomorphan XXX. Phenoperidine YYY. Phenyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylbenzamide (Other name: benzoyl fentanyl) ZZZ. Piritramide AAAA. Proheptazine BBBB. Properidine CCCC. Propiram DDDD. Racemoramide EEEE. N-(1- phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran- 2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other name: tetrahydrofuranyl fentanyl) FFFF. Thiofentany (N-phenyl- N-(1-(2-thienyl)ethyl-4- piperidinyl)- propanamide GGGG. Thiofuranyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-N-phenylthiophene- 2-carboxamide (Other names: 2-thiofuranyl fentanyl; thiophene fentanyl) HHHH. Tilidine IIII. Trimeperidine

1. A. Acetorphine
2. B. Acetyldihydrocodeine
3. C. Benzylmorphine
4. D. Codeine methylbromide
5. E. Codeine-N-Oxide
6. F. Cyprenorphine

7. G. Desomorphine

   1. 3. Opiate Similar Synthetic Substances.

   Substances scheduled by the United States Drug Enforcement Administration as substances that share a pharmacological profile similar to fentanyl, morphine, and other synthetic opioids, unless specifically excepted or unless listed in another schedule. These substances are—

   1. 4. Hallucinogenic substances. Unless

   specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)4. of this rule only, the term isomer includes the optical, position, and geometric isomers.):

   Some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;

   Some trade or other names: 4-bromo-2, 5- dimethoxy-a-methylphenethylamine; 4-bromo- 2, 5-DMA;

9054 Some trade or other names: 2,5-dimethoxy- 9055 amethylphenethylamine; 2,5-DMA; H. Dihydromorphine I. Drotebanol J. Etorphine (except hydrochloride salt) K. Heroin L. Hydromorphinol M. Methyldesorphine N. Methyldihydromorphine O. Morphine methylbromide P. Morphine methylsulfonate 9306 Q. Morphine-N-Oxide R. Myrophine S. Nicocodeine T. Nicomorphine U. Normorphine V. Pholcodine W. Thebacon

1. A. Butyryl fentanyl (N- (1-phenethylpiperidin-4-yl)- N-phenylbutyramide)
2. B. U–47700 (3,4-Dichloro- N-[2-(dimethylamino) cyclohexyl]-N- methylbenzamide)
3. C. N-(1-phenethylpiperidin- 4-yl)-N-phenylpentanamide (Other name: valeryl fentanyl)
4. A. Alpha-ethyltryptamine
5. B. 4-bromo-2,5- dimethoxyamphetamine
6. C. 4-bromo-2,5- dimethoxyphenethylamine
7. D. 2,5-dimethoxyamphetamine 7396
8. E. 2,5-dimethoxy-4- ethylamphetamine Some trade or other names: DOET;
9. F. 2,5-dimethoxy-4-(n)- propylthiophenethylamine (other name: 2C-T-7)
10. G. 2-(2,5-Dimethoxy-4-(n)- propylphenyl) ethanamine (2C-P)
11. H. 2-(2,5-Dimethoxy-4- ethylphenyl) ethanamine (2C-E )
12. I. 2-(2,5-Dimethoxy-4- methylphenyl) ethanamine (2C-D)
13. J. 2-(2,5-Dimethoxy-4-nitrophenyl) ethanamine (2C-N)
14. K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)
15. L. 2-(4-Chloro-2,5- dimethoxyphenyl) ethanamine (2C-C)
16. M. 2-(4-Ethylthio-2,5- dimethoxyphenyl) ethanamine (2C-T-2)
17. N. 2-(4-Iodo-2,5- dimethoxyphenyl) ethanamine (2C-I)
18. O. 2-(4-Isopropylthio)-2,5- dimethoxyphenyl) ethanamine (2C-T-4)
19. P. 4-methoxyamphetamine Some trade or other names: 4-methoxyamethylphenethylamine; paramethoxyamphetamine; PMA;
20. Q. 5-methoxy-3,4- methylenedioxyamphetamine 7401
21. R. 4-methyl-2,5- dimethoxyamphetamine Some trade and other names: 4-methyl-2, 5- dimethoxy-a-methylphenethylamine; DOM; and STP;
22. S. 3,4- methylenedioxyamphetamine 7400
23. T. 3,4-methylenedioxymethamphetamine(MDMA)
24. U. 3,4-methylenedioxy-N- ethylamphetamine (also known as N-ethylalphamethyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA) 7404
25. V. N-hydroxy-3,4- methylenedioxyamphetamine (also known as N-hydroxyalpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA)

26. W. 3,4,5- trimethoxyamphetamine Some trade and other names: 3-(b-Dimethy- 7348 laminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine;

    Some trade and other names: N, N-Diethyltryptamine; DET;

    Some trade or other names: DMT;

    Some trade and other names: 7-Ethyl- 6,6ß,7,8,9,10,12,13-octahydro-2-methoxy-6, 9-methano-5H-pyrido [1’,2’:1,2] azepino[5,4- b] indole; Tabernanthe iboga;

    Some trade or other names: marijuana;

    Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;

    Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts;

    contained in a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:

    nol and their optical isomers;

7402 cannabinol and their optical isomers;

7390 cannabinol and its optical isomers; and X. 5-MeO-DMT or 5-methoxy- N,N-dimethyltryptamine Y. Alpha-methyltryptamine Z. Bufotenine

AA. Diethyltryptamine

BB. Dimethyltryptamine

1. CC. 5-methoxy-N,N- diisopropyltryptamine (other name: 5- MeODIPT)
2. DD. Ibogaine

EE. Lysergic acid diethylamide 7315 FF. Marihuana

GG. Mescaline HH. Parahexyl

1. II. Peyote

JJ. N-ethyl-3-piperidyl benzilate KK. N-methyl-3-piperidyl benzilate LL. Psilocybin MM. Psilocyn NN. Tetrahydrocannabinols naturally

1. (I) 1 cis or trans tetrahydrocannabi-
2. (II) 6 cis or trans tetrahydro-

3. (III) 3,4 cis or trans tetrahydro- 7431 substances is not internationally standard- 7432 ized, compounds of these structures, regard- 7433 less of numerical designation of atomic positions are covered;

   Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl)

7434 ethylamine, N-(1-phenylcyclohexyl)-ethylamine, cyclohexamine, PCE;

Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;

7439 Some trade or other names: 1-(1-(2-thienyl)- 7260 cyclohexyl)-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP;

Some other names: TCPy; 19 CSR 30-1

1. (IV) Since nomenclature of these

OO. Ethylamine analog of phencyclidine

PP. Pyrrolidine analog of phencyclidine

QQ. Thiophene analog of phencyclidine

RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine

SS. Salvia divinorum TT. Salvinorin A UU. 3-Fluoromethcathinone VV. 4-Fluoromethcathinone WW. Mephedrone, or 4- methylmethcathinone XX. Methylenedioxypyrovalerone, MDPV, or (1-(1,3-Benzodioxol-5-yl)- 2-(1-pyrrolidinyl)-1- pentanone YY. Methylone, or 3,4- Methylenedioxymethcathinone ZZ. Quinolin-8-yl 1-pentyl- 1Hindole-3-carboxylate (PB-22; QUPIC) AAA. Quinolin-8-yl 1-(5- fluoropentyl)-1H-indole- 3-carboxylate (5-fluoro- PB-22; 5F-PB-22) BBB. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (4-fluorobenzyl)-1Hindazole- 3-carboxamide (AB- FUBINACA) CCC. N-(1-amino-3, 3-dimethyl-1- oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide (ADB-PINACA) DDD. (1-pentyl-1H-indol-3-yl) (2,2,3,3- tetramethylcyclopropyl) methanone (Other names: UR-144, 1-pentyl-3- (2,2,3,3- tetramethylcyclopropoyl)indole) AND SENIOR SERVICES

EEE. [1-(5-fluoro-pentyl)- 1Hindol-3-yl](2,2,3,3- tetramethylcyclopropyl) methanone (Other names: 5-fluoro-UR-144, 5-F-UR- 144, XLR11, 1-(5-fluoropentyl)-3-(2,2,3,3- tetramethylcyclopropoyl)indole) FFF. N-(1-adamantyl)-1-pentyl- 1Hindazole-3-carboxamide (Other names: APINACA, AKB48) GGG. 2-(4-iodo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (Other names: 251- NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) HHH. 2-(4-chloro-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (Other names: 25C- NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) III. 2-(4-bromo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (Other names: 25B- NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) JJJ. 4-methyl-N-ethylcathinone (Other names: 4-MEC; 2- (ethylamino)-1-(4- methylphenyl)propan- 1-one) KKK. 4-methyl-alphapyrrolidinopropiophenone, (Other names: 4-MePPP; MePPP; 4-methyl- α-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2- (pyrrolidin-1-yl)-propan- 1-one) LLL. alphapyrrolidinopentiophenone (Other names: α-PVP; α- pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one) MMM. Butylone (Other names: bk- MBDB; 1-(1,3- benzodioxol-5- yl)-2- (methylamino)butan-1- one) NNN. Pentedrone (Other names: α- methylaminovalerophenone; 2-(methylamino)-1- phenylpentan-1-one) OOO. Pentylone (Other names: bk- MBDP; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)pentan- 1-one) PPP. Naphyrone (Other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan- 1-one) QQQ. alpha-pyrrolidinobutiophenone (Other names: α-PBP; 1-phenyl-2-(pyrrolidin- 1-yl)butan-1-one) RRR. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole- 3-carboxamide (Other names: AB- CHMINACA) SSS. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl- 1Hindazole-3-carboxamide (Other names: AB-PINACA) TTT. [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen- 1-yl)methanone (Other names: THJ-2201) UUU. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (Other names: MAB- CHMINACA; ADB-CHMINACA) VVV. methyl 2-(1-(5- fluoropentyl)- 1H-indazole-3- carboxamido)-3,3- dimethylbutanoate (Other names: 5F–ADB; 5F–MDMB– PINACA) WWW. methyl 2-(1-(5- fluoropentyl)- 1H-indazole-3- carboxamido)-3- methylbutanoate (Other names: 5F– AMB) XXX. N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole- 3-carboxamide (Other names: 5F– APINACA, 5F– AKB48) YYY. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole- 3-carboxamide (Other names: ADB–FUBINACA) 7010 ZZZ. methyl 2-(1- (cyclohexylmethyl)- 1H-indole- 3-carboxamido)-3,3- dimethylbutanoate (Other names: MDMB–CHMICA, MMB–CHMINACA) 7042 AAAA. methyl 2-(1-(4- fluorobenzyl)- 1H-indazole- 3-carboxamido)-3,3- dimethylbutanoate (Other names: MDMB–FUBINACA) 7020 BBBB. methyl 2-(1-(4- fluorobenzyl)-1H- indazole- 3-carboxamido)-3- methylbutanoate (Other names: FUB–AMB, MMB– FUBINACA, AMB– FUBINACA) (7021) CCCC. 1-(1,3-benzodioxol- 5-yl)-2-(ethylamino) propan-1-one (ethylone) 7547 DDDD. Naphthalen-1-yl 1- (5-fluoropentyl)-1H- indole-3-carboxylate (Other names: NM2201; CBL2201) 7221 EEEE. N-(1-amino-3-methyl- 1-oxobutan-2-yl)-1- (5-fluoropentyl)-1H- indazole-3-carboxamide (Other name: 5F-AB- PINACA) 7025 FFFF. 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (Other names: 4-CN- CUMYLBUTINACA; 4-cyano-CUMYL- BUTINACA; 4-CN- CUMYLBINACA; CUMYL-4CNBINACA; SGT-78) 7089 GGGG. methyl 2-(1- (cyclohexylmethyl)-1H- indole-3-carboxamido)-3- methylbutanoate (Other names: MMB- CHMICA; AMB- CHMICA) 7044 HHHH. 1-(5-fluoropentyl)-N- (2-phenylpropan-2-yl)- 1H-pyrrolo[2,3-b] pyridine-3-carboxamide (Other name: 5F- CUMYL-P7AICA) 7085

1. IIII. N-ethylpentylone (Other names: ephylone, 1-(1,3- benzodioxol-5-yl)-2- (ethylamino)-pentan-1- one) 7543 JJJJ. methyl 2-(1-(4-fluorobutyl)- 1H-indazole-3- carboxamido)-3, 3-dimethylbutanoate (4F–MDMB–BINACA, 4F–MDMB– BUTINACA) 7043 KKKK. 1-(4-methoxyphenyl)-N- methylpropan-2-amine (Other names: paramethoxymethamphetamine, PMMA) 1245
2. LLLL. Synthetic cannabinoids:

Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. (I) Any compound structurally

derived from 3-(1-naphthoyl)indole or 1Hindol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:

1. (a) AM2201, or 1-(5- fluoropentyl)-3- (1-naphthoyl)indole 7201
2. (b) JWH-007, or 1- pentyl-2-methyl- 3-(1-naphthoyl)indole
3. (c) JWH-015, or 1-propyl- 2-methyl-3-(1- naphthoyl)indole
4. (d) JWH-018, or 1-pentyl- 3-(1-naphthoyl)indole 7118
5. (e) JWH-019, or 1-hexyl- 3-(1-naphthoyl)indole 7019
6. (f) JWH-073, or 1-butyl- 3-(1-naphthoyl)indole 7173
7. (g) JWH-081, or 1-pentyl- 3-(4-methoxy-1- naphthoyl)indole 7081
8. (h) JWH-098, or 1-pentyl- 2-methyl-3-(4- methoxy-1- naphthoyl)indole
9. (i) JWH-122, or 1-pentyl- 3-(4-methyl-1- naphthoyl)indole 7122
10. (j) JWH-164, or 1-pentyl- 3-(7-methoxy-1- naphthoyl)indole
11. (k) JWH-200, or 1-(2-(4- (morpholinyl)ethyl))-3- (1-naphthoyl)indole 7200
12. (l) JWH-210, or 1-pentyl- 3-(4-ethyl-1- naphthoyl)indole
13. (m) JWH-398, or 1-pentyl- 3-(4-chloro-1- naphthoyl)indole 7398
14. (II) Any compound structurally

derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (III) Any compound structurally

derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (IV) Any compound structurally

derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) JWH-201, or 1-pentyl- 3-(4- methoxyphenylacetyl)indole
2. (b) JWH-203, or 1-pentyl- 3-(2- chlorophenylacetyl)indole 7203
3. (c) JWH-250, or 1-pentyl- 3-(2-methoxyphenylacetyl)indole 6250
4. (d) JWH-251, or 1-pentyl- 3-(2- methylphenylacetyl)indole
5. (e) RCS-8, or 1-(2- cyclohexylethyl)-3-(2- methoxyphenylacetyl)indole 7008 19 CSR 30-1
6. (V) Any compound structurally

derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:

1. (a) CP 47,497 & homologues, or

2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4, 6, or 7 7297, 7298

1. (VI) Any compound containing a 3-

(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) AM-694, or 1-(5- fluoropentyl)-3-(2- iodobenzoyl)indole 7694
2. (b) RCS-4, or 1-pentyl-3-(4- methoxybenzoyl)indole (SR-19 and RCS-4) 7104
3. (VII) CP 50,556-1, or

[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3- [ ( 2 R ) - 5 - p h e n y l p e n t a n - 2 - y l ] o x y - 5,6,6a,7,8,9,10,10a-octahydrophenanthridin- 1-yl] acetate; (VIII) HU-210, or (6aR,10aR)-9- (hydroxymethyl)-6,6-dimethyl-3-(2-methyl o c t a n - 2 - y l ) - 6 a , 7 , 1 0 , 1 0 a - tetrahydrobenzo[c]chromen-1-ol;

1. (IX) HU-211, or

Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1- ol;

1. (X) Dimethylheptylpyran, or

DMHP.

1. 5. Depressants. Unless specifically

excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Gamma-hydroxybutyric acid and

other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate 2010

1. B. Mecloqualone 2572
2. C. Methaqualone 2565
3. 6. Stimulants. Unless specifically

excepted or unless listed in another schedule, AND SENIOR SERVICES

any material, compound, mixture, or prepacycle, whether or not further substituted in or ration which contains any quantity of the folon the monocycle; lowing substances having a stimulant effect on the central nervous system, including its phenethyl group with alkyl, alkenyl, alkoxyl, salts, isomers, and salts of isomers: hydroxyl, halo, haloalkyl, amino, or nitro

1. A. Aminorex 1585 groups;

Some trade or other names: aminoxaphen; 2- amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- piperidine ring with alkyl, alkenyl, alkoxyl, phenyl-2-oxazolamine; ester, ether, hydroxyl, halo, haloalkyl,

1. B. N-benzylpiperazine (some amino, or nitro groups; other names: BZP, 1- benzylpiperzaine) 7493 ring with any aromatic monocycle whether or
2. C. Cathinone (Some trade or not further substituted in or on the aromatic other names: 2-amino-1- monocycle; and/or phenyl-1-propanone, alphaaminopropiophenone, onyl group by another acyl group. 2-aminopropiophenone and norephedrone) 1235
3. D. 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- methyl-5-(4-methylphenyl)-2- oxazolamine; 4-methyl-5-(4- methylphenyl)-4,5-dihydro- 1,3-oxazol-2-amine) 1595
4. E. Fenethylline 1503
5. F. Methcathinone 1237

Some trade or other names: 2-(methylamino)- propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan- 1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinine; AL-464; AL- 422; AL-463 and URI 432;

1. G. 4-methoxymethcathinone
2. H. cis-4-methylaminorex (cis-4,5-dihydro-4-methyl- 5-phenyl-2-oxazolamine) 1590
3. I. 4-Methyl-alphapyrrolidinobutiophenone, or MPBP
4. J. N-ethylamphetamine 1475
5. K. N,N-dimethylamphetamine 1480

(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alphatrimethylphenethylamine)

1. 7. A temporary listing of substances

subject to emergency scheduling under federal law shall include any material, compound, mixture, or preparation which contains any quantity of the following substances:

1. A. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers. 9850

   1. (I) Fentanyl-related substance

means any substance not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:

1. (a) Replacement of the phenyl

portion of the phenethyl group by any mono-

1. (b) Substitution in or on the
2. (c) Substitution in or on the
3. (d) Replacement of the aniline
4. (e) Replacement of the N-propi-

1. B. ethyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: 5F-EDMB- PINACA) 7036
2. C. methyl 2-(1-(5-fluoropentyl)- 1H-indole-3-carboxamido)-3,3- dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: 5F-MDMB-PICA) 7041
3. D. N-(adamantan-1-yl)-1-(4- fluorobenzyl)-1H-indazole-3- carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial names: FUB-AKB48; FUB- APINACA; AKB48 N-(4- FLUOROBENZYL)) 7047
4. E. 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial names: 5F-CUMYL-PINACA; SGT-25) 7083
5. F. (1-(4-fluorobenzyl)-1H- indol-3-yl)(2,2,3,3- tetramethylcyclopropyl) methanone, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: FUB-144) 7014
6. G. N-Ethylhexedrone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other name: 2- (ethylamino)-1- phenylhexan-1-one) 7246
7. H. alpha-Pyrrolidinohexanophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: α-PHP; alphapyrrolidinohexiophenone; 1- phenyl-2-(pyrrolidin-1- yl)hexan-1-one) 7544
8. I. 4-Methyl-alphaethylaminopentiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 4-MEAP; 2- (ethylamino)-1- (4-methylphenyl)pentan-1- one) 7245
9. J. 4′-Methyl-alphapyrrolidinohexiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: MPHP; 4'-methylalpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)- 2-(pyrrolidin-1-yl)hexan-1- one) 7446
10. K. alpha-Pyrrolidinoheptaphenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PV8; 1-phenyl-2- (pyrrolidin-1-yl)heptan-1- one) 7548
11. L. 4'-Chloro-alphapyrrolidinovalerophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 4-chloro-α-PVP; 4'- chloro-alphapyrrolidinopentiophenone; 1- (4-chlorophenyl)-2-(pyrrolidin- 1-yl) pentan-1-one) 7443
12. M. N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro- 1H-benzimidazol-1-yl)ethan- 1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: isotonitazene; N,N-diethyl-2-[[4- (1- methylethoxy) phenyl]methyl]-5-nitro-1H- benzimidazole-1- ethanamine) 9614

13. N. 1-(1-(1-(4-bromophenyl) ethyl)piperidin-4-yl)-1, 3- dihydro-2H-benzo[d]imidazol- 2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: brorphine; 1-[1-[1-(4-bromophenyl)ethyl]-4- piperidinyl]-1,3-dihydro- 2H-benzimidazol-2-one) 9098

    1. 8. Khat, to include all parts of the plant

presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed, or extracts.

1. (B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.

   1. 1. Substances, vegetable origin, or

chemical synthesis. Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

1. A. Opium and opiate; and any salt,

compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:

1. (I) Raw opium
2. (II) Opium extracts
3. (III) Opium fluid
4. (IV) Powdered opium
5. (V) Granulated opium
6. (VI) Tincture of opium
7. (VII) Codeine (VIII) Dihydroetorphine
8. (IX) Ethylmorphine
9. (X) Etorphine hydrochloride 9059
10. (XI) Hydrocodone
11. (XII) Hydromorphone (XIII) Metopon
12. (XIV) Morphine
13. (XV) Oripavine
14. (XVI) Oxycodone (XVII) Oxymorphone (XVIII) Thebaine
15. B. Any salt, compound, derivative, or

preparation thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;

1. C. Opium poppy and poppy straw
2. D. Coca leaves (9040) and any salt,

compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:

extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or

crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy)

1. 2. Opiates. Unless specifically excepted

or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:

9620 Some other names: 9639 methadol, levomethadyl acetate, 9640 LAAM

1. (I) Decocainized coca leaves or
2. (II) Ioflupane;

1. E. Concentrate of poppy straw (the
2. A. Alfentanil
3. B. Alphaprodine
4. C. Anileridine
5. D. Bezitramide
6. E. Bulk Dextropropoxyphene (Non-dosage Forms)
7. F. Carfentanil
8. G. Dihydrocodeine
9. H. Diphenoxylate
10. I. Fentanyl
11. J. Isomethadone
12. K. Levo-alphacetylmethadol levo-alphaacetyl-
13. L. Levomethorphan
14. M. Levorphanol
15. N. Metazocine
16. O. Methadone
17. P. Methadone-Intermediate, 4-cyano-2-dimethylamino- 4,4-diphenyl butane
18. Q. Moramide-Intermediate, 2- methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid
19. R. Oliceridine (N-[(3- methoxythiophen-2-yl) methyl] ({2-[(9R)-9-(pyridin- 2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl})amine fumarate) 9245
20. S. Pethidine (Meperidine)
21. T. Pethidine-Intermediate-A, 4-cyano-1-methyl-4- phenylpiperidine
22. U. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4- carboxylate
23. V. Pethidine-Intermediate-C, 1- methyl-4-phenylpiperidine- 4-carboxylic acid
24. W. Phenazocine

25. X. Piminodine

    1. 3. Stimulants. Unless specifically

    excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

    1. 4. Depressants. Unless specifically

    excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

    1. 5. Hallucinogenic substances:

    Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 1-hydroxy-6, 6-dimethyl-9H-dibenzo(b,d) pyran-9-one.

    tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration.

    1. 6. Immediate precursors. Unless specif-

    ically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

    amphetamine and methamphetamine:

9233 Some trade or other names: phenyl-2- propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

9715 dine (PCP): 19 CSR 30-1

1. Y. Racemethorphan
2. Z. Racemorphan AA. Remifentanil BB. Sufentanil
3. CC. Tapentadol
4. DD. Thiafentanil
5. A. Amphetamine, its salts, optical isomers, and salts of its optical isomers
6. B. Lisdexamfetamine, its salts, isomers, and salts of its isomers
7. C. Methamphetamine, its salts, isomers, and salts of its isomers
8. D. Phenmetrazine and its salts 1631
9. E. Methylphenidate
10. A. Amobarbital
11. B. Glutethimide
12. C. Pentobarbital
13. D. Phencyclidine
14. E. Secobarbital
15. A. Nabilone

16. B. Dronabinol [(-)-delta-9-trans

    (7365)

17. A. Immediate precursor

    1. (I) Phenylacetone

18. B. Immediate precursors to phencycli-

    1. (I) 1-phenylcyclohexylamine 7460 to AND SENIOR SERVICES

       1. (II) 1-piperidinocyclohexanecarbonitrile (PCC)

       2. C. Immediate precursor to fentanyl:

          1. (I) 4-anilino-N-phenethyl-4- piperidine (ANPP)
          2. (II) N-phenyl-N-(piperidin- 4-yl)propionamide (norfentanyl)
       3. 7. Any material, compound, mixture, or

preparation which contains any quantity of the following alkyl nitrites:

1. A. Amyl nitrite;
2. B. Butyl nitrite.

3. (C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Stimulants. Unless specifically

excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Those compounds, mixtures, or

preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32 and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances

1. B. Benzphetamine
2. C. Chlorphentermine
3. D. Clortermine
4. E. Phendimetrazine
5. 2. Depressants. Unless specifically

excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

1. A. Any compound, mixture, or

preparation containing—

1. (I) Amobarbital
2. (II) Secobarbital
3. (III) Pentobarbital

or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;

1. B. Any suppository dosage form con-

taining—

1. (I) Amobarbital
2. (II) Secobarbital or any salt of any of these drugs and approved

8603 by the Food and Drug Administration for marketing only as a suppository;

8333 quantity of a derivative of barbituric acid or any salt thereof

gamma hydroxybutyric acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;

Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2-thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4- ( 2 - f l u o ro p h e ny l ) - 6 - 8 - d i hyd ro - 1 , 3 , 8 - trimethylpyrazolo-(3,4-e) 7(1H)-one, flupyrazapon.

1. 3. Nalorphine

1405 4. Narcotics drugs. Unless specifically 1228 excepted or unless listed in another schedule, 1645 any material, compound, mixture, or prepa- 1647 ration containing limited quantities of any of 1615 the following narcotic drugs or any salts thereof:

grams (1.8gm) of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium

2126 grams (1.8gm) of codeine per one hundred 2316 milliliters (100 mL) or not more than ninety 2271 milligrams (90 mg) per dosage unit, with one

1. (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

grams (1.8gm) of dihydrocodeine per one hundred milliliters (100 mL) or not more

2126 than ninety milligrams (90 mg) per dosage 2316 unit, with one (1) or more active, nonnarcot-

1. (III) Pentobarbital

1. C. Any substance which contains any
2. D. Chlorhexadol
3. E. Embutramide
4. F. Any drug product containing
5. G. Ketamine, its salts, isomer, and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2- (methylamino)- cyclohexanone)
6. H. Lysergic acid
7. I. Lysergic acid amide
8. J. Methyprylon
9. K. Perampanel, and its salts, isomers, and salts of isomers
10. L. Sulfondiethylmethane
11. M. Sulfonethylmethane
12. N. Sulfonmethane

13. O. Tiletamine and zolazepam or any salt thereof

    (1,4)-diazepin-

14. A. Not more than one and eight tenths
15. B. Not more than one and eight tenths

16. C. Not more than one and eight tenths 2271 ic ingredients in recognized therapeutic amounts 9807

    1. D. Not more than three hundred mil-

    ligrams (300 mg) of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts 9808

    1. E. Not more than five hundred mil-

    ligrams (500 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts 9809

    1. F. Not more than fifty milligrams (50

    mg) of morphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts 9810

    1. 5. Any material, compound, mixture, or

    preparation containing any of the following narcotic drugs or their salts, as set forth below:

    1. A. Buprenorphine 9064
    2. 6. Anabolic steroids. Unless specially

    excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation. DEA has assigned code 4000 for all anabolic steroids. Anabolic steroids. Any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that promotes muscle growth, except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this paragraph. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers:

    1. A. 3β,17β-dihydroxy-5α-androstane
    2. B. 3α,17β-dihydroxy-5α-androstane
    3. C. 5α-androstan-3,17-dione
    4. D. 1-androstenediol (3β,17β-dihy-

    droxy-5α-androst-1-ene)

    1. E. 1-androstenediol (3α,17β-dihy-

    droxy-5α-androst-1-ene) F. 4-androstenediol (3β,17β-dihy-

droxy-androst-4-ene)

1. G. 5-androstenediol (3β,17β-dihy-

droxy-androst-5-ene)

1. H. 1-androstenedione ([5α]-androst-

1-en-3,17-dione)

1. I. 4-androstenedione (androst-4-en-

3,17-dione)

1. J. 5-androstenedione (androst-5-en-

3,17-dione)

1. K. Bolasterone (7α,17α-dimethyl-

17β-hydroxyandrost-4-en-3- one)

1. L. Boldenone (17β-hydroxyandrost-1,

4-diene-3-one)

1. M. Boldione (androstra-1,4-diene-

3,17-dione)

1. N. Calusterone (7β,17α-dimethyl-

17β-hydroxyandrost-4-en-3-one)

1. O. Clostebol (4-chloro-17β-hydrox-

yandrost-4-en-3-one)

1. P. Dehydrochloromethyltestosterone

(4-chloro-17β-hydroxy-17α-methyl-androst- 1, 4-dien-3-one)

1. Q. Desoxymethyltestosterone (17α-

methyl-5α-androst-2-en-17β-ol) (a.k.a. madol)

1. R. Δ1-dihydrotestosterone (a.k.a.’1-

testosterone’)(17β- hydroxy-5α-androst-1-en- 3-one)

1. S. 4-dihydrotestosterone (17β-

hydroxy-androstan-3-one)

1. T. Drostanolone (17β-hydroxy-2α-

methyl-5α-androstan-3-one)

1. U. Ethylestrenol (17α-ethyl-17β-

hydroxyestr-4-ene)

1. V. Fluoxymesterone (9-fluoro-17α-

methyl-11β,17β-dihydroxyandrost-4-en-3- one)

1. W. Formebulone (Formebolone) (2-

formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)

1. X. Furazabol (17α-methyl-17β-

hydroxyandrostano[2,3-c]-furazan)

1. Y. 13β-ethyl-17β-hydroxygon-4-en-3-

one

1. Z. 4-hydroxytestosterone (4,17β-

dihydroxy-androst-4-en-3-one) AA. 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one) BB. Mestanolone (17α-methyl-17β- hydroxy-5α-androstan-3-one)

1. CC. Mesterolone (1α-methyl-17β-

hydroxy-[5α]-androstan-3-one)

1. DD. Methandienone (17α-methyl-

17β-hydroxyandrost-1,4-dien-3-one) EE. Methandriol (17α-methyl- 3β,17β-dihydroxyandrost-5-ene) FF. Methasterone (2α,17α-dimethyl- 5α-androstan-17β-ol-3-one) GG. Methenolone (1-methyl-17β- hydroxy-5α-androst-1-en-3-one) HH. 17α-methyl-3β,17β-dihydroxy- 5α-androstane

1. II. 17α-methyl-3α,17β-dihydroxy-5α-

androstane JJ. 17α-methyl-3β,17β-dihydroxyandrost-4-ene KK. 17α-methyl-4-hydroxynandrolone(17α-methyl-4-hydroxy-17β-hydroxyestr-4- en-3-one)

1. LL. Methyldienolone (17α-methyl-

17β-hydroxyestra-4,9(10)-dien-3-one)

1. MM. Methyltrienolone (17α-methyl-

17β-hydroxyestra-4,9,11-trien-3-one) NN. Methyltestosterone (17α-methyl- 17-hydroxyandrost-4-en-3-one) OO. Mibolerone (7α,17α-dimethyl- 17β-hydroxyestr-4-en-3-one) PP. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst- 1-en-3-one) (a.k.a. 17-α-methyl-1-testosterone) QQ. Nandrolone (17β-hydroxyestr-4- ene-3-one) R R . 1 9 - n o r - 4 - a n d r o s t e n e d i o l (3β,17β-dihydroxyestr-4-ene) SS. 19-nor-4-andro stenediol (3α,17β-dihydroxyestr-4-ene) TT. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) U U . 1 9 - n o r - 5 - a n d r o s t e n e d i o l (3β,17β-dihydroxyestr-5-ene) V V. 1 9 - n o r - 5 - a n d r o s t e n e d i o l (3α,17β-dihydroxyestr-5-ene) WW. 19-nor-4-androstenedione (estr- 4-en-3,17-dione)

1. XX. 19-nor-5-androstenedione (estr-

5-en-3,17-dione) YY. Norbolethone (13β,17α-diethyl- 17β-hydroxygon-4-en-3-one) ZZ. Norclostebol (4-chloro-17β- hydroxyestr-4-en-3-one) AAA. Norethandrolone (17α-ethyl- 17β-hydroxyestr-4-en-3-one) BBB. Normethandrolone (17α- methyl-17β-hydroxyestr-4-en-3-one)

1. CCC. Oxandrolone (17α-methyl-17β-

hydroxy-2-oxa-[5α]-androstan-3-one)

1. DDD. Oxymesterone (17α-methyl-

4,17β-dihydroxyandrost-4-en-3-one) EEE. Oxymetholone (17α-methyl-2- hyd rox y m e t hy l e n e - 1 7 β - hyd rox y - [ 5 α ] - androstan-3-one) FFF. Prostanozol (17β-hydroxy-5α- androstano[3,2-c]pyrazole) GGG. Stanolone (Δ1-dihydrotestosterone (a.k.a. 1-testosterone)(17β-hydroxy- 5α-androst-1-en-3-one)) HHH. Stanozolol (17α-methyl-17β- hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole)

1. III. Stenbolone (17β-hydroxy-2-

methyl-[5α]-androst-1-en-3-one) JJJ. Testolactone(13-hydroxy-3-oxo- 13,17-secoandrosta-1,4-dien-17-oic acid lactone) KKK. Testosterone(17β-hydroxyandrost-4-en-3-one);

1. LLL. Tetrahydrogestrinone (13β,17α- 19 CSR 30-1

diethyl-17β-hydroxygon-4,9, 11-trien-3-one)

1. MMM. Trenbolone (17β-hydroxyestr-

4,9,11-trien-3-one) NNN. Any salt, ester, or isomer of a drug or substance described or listed in this subparagraph, if that salt, ester, or isomer promotes muscle growth except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration.

1. 7. Dronabinol (synthetic) in sesame oil

and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369 (Some other names for dronabinol: (6aRtrans)- 6a,7,8,10a-tetrahydro-6.6.9- trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1- ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)

1. (D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Narcotic drugs. Unless specifically

excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

1. A. Not more than one milligram (1

mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit 9167

1. B. Dextropropoxyphene (alpha-(+)-

4-dimethylamino-1,2-diphenyl-3-methyl-2- propionoxybutane) 9278

1. C. 2-[(dimethylamino)methyl]-1-(3-

methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol) 9752

1. D. Narcotic drugs containing nonnar-

cotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1. (I) Not more than two hundred mil-

ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. (II) Not more than one hundred

milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one AND SENIOR SERVICES

hundred grams (100 gm); or

1. (III) Not more than one hundred

milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).

1. 2. Depressants. Unless specifically

excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Alfaxalone
2. B. Alprazolam
3. C. Barbital
4. D. Brexanolone
5. E. Bromazepam
6. F. Camazepam
7. G. Carisoprodol
8. H. Chloral betaine
9. I. Chloral hydrate
10. J. Chlordiazepoxide
11. K. Clobazam
12. L. Clonazepam
13. M. Clorazepate
14. N. Clotiazepam
15. O. Cloxazolam
16. P. Delorazepam
17. Q. Diazepam
18. R. Dichloralphenazone
19. S. Estazolam
20. T. Ethchlorvynol
21. U. Ethinamate
22. V. Ethyl loflazepate
23. W. Fludiazepam
24. X. Flunitrazepam
25. Y. Flurazepam
26. Z. Fospropofol AA. Halazepam BB. Haloxazolam
27. CC. Ketazolam
28. DD. Lemborexant EE. Loprazolam FF. Lorazepam GG. Lormetazepam HH. Mebutamate
29. II. Medazepam JJ. Meprobamate KK. Methohexital
30. LL. Methylphenobarbital (Mephobarbital)
31. MM. Midazolam NN. Nimetazepam OO. Nitrazepam PP. Nordiazepam QQ. Oxazepam RR. Oxazolam SS. Paraldehyde TT. Petrichloral UU. Phenobarbital

32. VV. Pinazepam WW. Prazepam

    1. 3. Fenfluramine. Any material, com-

    pound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

    1. 4. Lorcaserin. Any material, compound,

    mixture, or preparation which contains any

2460 quantity of the following substances, includ- 2465 ing its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

1. 5. Stimulants. Unless

excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

1. 6. Other substances. Unless specifically

excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:

1. XX. Quazepam YY. Remimazolam ZZ. Suvorexant AAA. Temazepam BBB. Tetrazepam
2. CCC. Triazolam
3. DDD. Zaleplon EEE. Zolpidem FFF. Zopiclone
4. A. Fenfluramine
5. A. Lorcaserin specifically
6. A. Cathine ((+)- norpseudoephedrine)
7. B. Diethylpropion
8. C. Fencamfamin
9. D. Fenproporex
10. E. Mazindol
11. F. Mefenorex
12. G. Modafinil
13. H. Pemoline (including organometallic complexes and chelates thereof)
14. I. Phentermine
15. J. Pipradrol
16. K. Serdexmethylphenidate
17. L. Sibutramine
18. M. Solriamfetol (2-amino-3- phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester)) 1650
19. N. SPA (-)-1-dimethylamino- 1,2-diphenylethane
20. A. Pentazocine

21. B. Butorphanol (including its optical isomers)

    1. 7. Ephedrine. Any material, compound,

    mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including their salts, isomers, and salts of isomers:

    mers, or salts of optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical insignificant quantities of another active medicinal ingredient.

    1. (E) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection.

       1. 1. Narcotic drugs containing nonnarcot-

    ic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1680 ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

ligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

ligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

milligrams (2.5 mg) of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;

ligrams (100 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and

ligram (0.5 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five

9720 micrograms (25 mcg) of atropine sulfate per C. Eluxadoline (5-[[[(2S)-2- amino-3-[4-aminocarbonyl)- 2,6-dimethylphenyl]-1- oxopropyl] [(1S)-1-(4-phenyl- 1 H-imidazol-2- yl)ethyl]amino]methyl]-2- methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers 9725

1. A. Ephedrine or its salts, optical iso-

   isomers and therapeutically

2. A. Not more than two hundred mil-
3. B. Not more than one hundred mil-
4. C. Not more than one hundred mil-
5. D. Not more than two and five-tenths
6. E. Not more than one hundred mil-

7. F. Not more than five-tenths mildosage unit.

   1. 2. Stimulants. Unless specifically

exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including its salts, isomers, and salts of isomers:

1. A. Pyrovalerone
2. 3. Any compound, mixture, or prepara-

tion containing any detectable quantity of pseudoephedrine or its salts or optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starchbased solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:

1. A. Drug preparations in liquid form;
2. B. Drug preparations that require a

prescription in order to be dispensed.

1. 4. Unless specifically exempted or

excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

1. A. Ezogabine [N-[2-amino-4(4- fluorobenzylamino)-phenyl]- carbamic acid ethyl ester]
2. B. Lacosamide [(R)-2- acetoamido-N-benzyl- 3-methoxy-propionamide]
3. C. Pregabalin [(S)-3- (aminomethyl)-5- methylhexanoic acid]
4. D. Brivaracetam ((25)-2-[(4R)- 2-oxo-4-propylpyrrolidin-1- yl]butanamide) (also referred to as BRV; UCB-34714; Briviact)
5. E. Lasmiditan [2,4,6- trifluoro-N-(6-(1- methylpiperidine-4- carbonyl) pyridine-2- yl-benzamide]
6. F. Cenobamate ([(1R)-1-(2- chlorophenyl)-2-(tetrazol- 2-yl)ethyl] carbamate; 2H- tetrazole-2-ethanol, alpha-(2- chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2- chlorophenyl)-2-(2H-tetrazol- 2-yl)ethyl ester)

1. (2) Excluded Nonnarcotic Substances. The following nonnarcotic substances which, 19 CSR 30-1

   under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301) and section 201(g)(1) of the federal Controlled Substances Act (21 U.S.C. 811(g)(1)), may be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 195.015(5), RSMo. AND SENIOR SERVICES

Company

Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs

AUTHORITY: section 195.015, RSMo Supp. 2021, and section 195.195, RSMo 2016.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. Emergency amendment filed Oct. 25, 2018, effective Nov. 4, 2018, expired May 2, 2019. Amended: Filed Oct. 25, 2018, effective April 30, 2019. Emergency amendment filed Oct. 30, 2020, effective Nov. 16, 2020, expired May 14, 2021. Amended: Filed Oct. 30, 2020, effective April 30, 2021. Emergency amendment filed Sept. 28, 2021, effective Oct. 13, 2021, expired April 10, 2022. Amended: Filed Sept. 28, 2021, effective March 30, 2022. *Original authority: 195.015, RSMo 1971, amended 1989, 2014, 2020, and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014.